KYTX
Kyverna Therapeutics, Inc. - Common Stock (KYTX)
$04
About Kyverna Therapeutics, Inc. - Common Stock (KYTX)
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Details
Daily high
$2.12
Daily low
$2.00
Price at open
$2.11
52 Week High
$17.55
52 Week Low
$1.78
Market cap
90.8M
Dividend yield
0.00%
Volume
80,393
Avg. volume
263,672
P/E ratio
-.61
Kyverna Therapeutics, Inc. - Common Stock News
Details
Daily high
$2.12
Daily low
$2.00
Price at open
$2.11
52 Week High
$17.55
52 Week Low
$1.78
Market cap
90.8M
Dividend yield
0.00%
Volume
80,393
Avg. volume
263,672
P/E ratio
-.61